News and features

Articles

Article Type
Jurisdiction
Practice area

Showing 181 - 190 of 542

News & Analysis

IP people moves and firm announcements: Americas

31 August 2021 by Chris Adams

Read the latest IP practitioner and firm news in the Americas

News & Analysis

Benchmark Asia-Pacific 2022 - RESEARCH HAS BEGUN

23 August 2021 by Candice Mak

Learn about why it is important to participate in the research

News & Analysis

Benchmark Litigation 中国 2022 - 调研现已开始

23 August 2021 by Annie Wang

欢迎来到Benchmark Litigation中国

News & Analysis

Benchmark's Top 50 Women in Litigation - Canada for 2021 is now revealed!

05 August 2021 by Benchmark Canada

Congratulations to the selectees for Benchmark's Top 50 Women in Litigation - Canada list!

News & Analysis

The 2021 Top 10 Women in Litigation list is revealed!

05 August 2021 by Benchmark Litigation

Benchmark Litigation's Top 10 Women in Litigation list is out now!

News & Analysis

Benchmark 40 & Under Hot List 2021 - NOW LIVE

19 July 2021 by

2021 edition of Benchmark's 40 & Under Hot List is officially revealed!

News & Analysis

Hong Kong’s pivotal role as the Greater Bay Area’s dispute resolution center, supported by the Hong Kong and Mainland China governments

29 June 2021 by Kareena Teh

Hong Kong has a pivotal role in the Greater Bay Area (“GBA”). Comprising the nine Mainland China cities of Guangzhou, Shenzhen, Zhuhai, Foshan, Huizhou, Dongguan, Zhongshan, Jiangmen, Zhaoqing and the Special Administrative Regions (“SARs”) of Hong Kong and Macao, the GBA spans an area of 56,000 km2 with a combined population of over 72 million and ranks as the world’s 12th largest economy.

News & Analysis

Q&A with Yueping Zhou of Zhong Lun Law Firm

28 June 2021 by Yueping Zhou

Benchmark Litigation interviews one of Asia-Pacific's Top Women Litigators

News & Analysis

Benchmark Asia-Pacific's Top 100 Women in Litigation 2021

21 June 2021 by Joanna Yang

The 2021 Top 100 Women in Litigation guide is now LIVE!

News & Analysis

China’s drug-patent linkage system has landed

16 June 2021 by Lili Wu, Ying Li, Yulian Hu and Linlin Zhang

Lili Wu, Ying Li, Yulian Hu and Linlin Zhang of Han Kun Law Offices explain how China’s drug-patent linkage system promotes and encourages innovation and development of the pharmaceutical industry